Mon, Oct 20, 2014, 11:47 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • benarnd10 benarnd10 Aug 14, 2013 3:07 PM Flag

    Get with it Oculus Management

    At some point management must realize that the lower that OCLS goes the more difficult it is to sell a piece of the company for twice what the entire company is selling for. They must focus on Oculus sales which have been lackluster, do deals and sell licenses to bring in cash so that investors do not have to fear another dilutive equity offering. Focus management, it is our best hope. Absolutely no one believes that the Ruthigen IPO will happen - so let's get back to the business of OCLS which is to sell product.

0.7151-0.0220(-2.98%)Oct 20 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.